Trends in cancer mortality in Switzerland, 1951-1984
- PMID: 3368605
Trends in cancer mortality in Switzerland, 1951-1984
Abstract
Trends in overall age-standardized, truncated (35-64 years) and age-specific (40 to 49) cancer death certification rates in Switzerland from 1951 to 1984 were analysed. There was a substantial rise in lung cancer mortality in males, with an over 100% increase in overall rates. Thus, in the early 1980's, lung cancer alone accounted for 26% of all cancer deaths in Swiss males. However, male lung cancer rates tended to level off in subsequent cohorts starting from younger middle age in the late 1960's. In females, lung cancer mortality was approximately ten times lower than in males, but rates had been consistently rising since the late 1960's in all age groups. Declines were observed for several neoplasms of the digestive tract: besides stomach (overall decline 68% in males, 77% in females), trends were markedly downwards also for oesophageal cancer in males (-57%), and there was some moderate fall for intestinal sites in both sexes and gallbladder in females. Several trends for other common neoplasms were similar to those observed in other developed countries, such as the declines for (cervix) uteri, the general stability for breast cancer, or the increases in pancreatic cancer and (melanoma) of the skin. A peculiar feature of Swiss data, besides the marked decline in oesophageal cancer in males, was the consistent downward trend in thyroid cancer for both sexes. Thus, overall age-standardized total cancer mortality over the last three decades was moderately upwards in Swiss males, but consistently downwards in females. Male trends were more reassuring in middle age, chiefly in consequence of the flattening in lung cancer rises. Possible interpretations of these trends in terms of aetiological hypotheses (i.e., changes in alcohol drinking and improvements in diet for oesophageal cancer, or reduced prevalence of iodine deficiency for thyroid neoplasms) are discussed.
PIP: Trends in cancer mortality from 1951 to 1984 are analyzed by age, sex, and cancer site using official Swiss data. A substantial rise in lung cancer mortality among males is noted, although a decline is seen among younger cohorts. Mortality from lung cancer among females is 10 times lower than for males but shows signs of an increase. Declines in mortality from cancer of the digestive tract for both sexes were apparent. Overall age-standardized cancer mortality was moderately up for males but consistently down for females. Reasons for these trends are discussed. Comparisons are then made with other developed countries.
Similar articles
-
[Trends in mortality from respiratory tract tumors in Italy, 1969-1987].Ann Ist Super Sanita. 1992;28(1):21-34. Ann Ist Super Sanita. 1992. PMID: 1497244 Italian.
-
Trends in cancer mortality sex ratios in Europe, 1950-1989.World Health Stat Q. 1992;45(1):117-64. World Health Stat Q. 1992. PMID: 1413853
-
[Trends in the mortality from stomach tumors in Italy from 1951 to 1981].Ann Ig. 1989 Jan-Apr;1(1-2):109-24. Ann Ig. 1989. PMID: 2483058 Review. Italian.
-
Trend surface models in the representation and analysis of time factors in cancer mortality.Rev Epidemiol Sante Publique. 1990;38(3):237-43. Rev Epidemiol Sante Publique. 1990. PMID: 2396037
-
[Cancer epidemiology and trends in Switzerland].Bull Cancer. 2007 Sep;94(9):775-80. Bull Cancer. 2007. PMID: 17878097 Review. French.
Cited by
-
Sex differentials in Swiss cancer mortality.Soz Praventivmed. 1988;33(3):140-3. doi: 10.1007/BF02078420. Soz Praventivmed. 1988. PMID: 3213232
-
Pancreatic cancer - a continuing challenge in oncology.Pathol Oncol Res. 2003;9(4):252-63. doi: 10.1007/BF02893388. Epub 2003 Dec 22. Pathol Oncol Res. 2003. PMID: 14688834 Review.
-
Cancer mortality in Switzerland, 1985-89.Soz Praventivmed. 1991;36(2):112-26. doi: 10.1007/BF01846050. Soz Praventivmed. 1991. PMID: 1867011 No abstract available.
-
The application of trend surface models to the analysis of time factors in Swiss cancer mortality.Soz Praventivmed. 1988;33(7):359-73. doi: 10.1007/BF02084305. Soz Praventivmed. 1988. PMID: 3223104
-
Anti-inflammatory effects of the Nigella sativa seed extract, thymoquinone, in pancreatic cancer cells.HPB (Oxford). 2009 Aug;11(5):373-81. doi: 10.1111/j.1477-2574.2009.00059.x. HPB (Oxford). 2009. PMID: 19768141 Free PMC article.